PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment.
- DOI
- 10.1038/srep09384
- Published
- 2015 Mar 30
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/srep09384,
title = {PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment.},
author = {Lam W and Jiang Z and Guan F and Huang X and Hu R and Wang J and Bussom S and Liu SH and Zhao H and Yen Y and Cheng YC},
year = {2015},
journal = {Scientific reports},
doi = {10.1038/srep09384},
url = {https://doi.org/10.1038/srep09384}
}RIS
TY - JOUR TI - PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment. AU - Lam W AU - Jiang Z AU - Guan F AU - Huang X AU - Hu R AU - Wang J AU - Bussom S AU - Liu SH AU - Zhao H AU - Yen Y AU - Cheng YC PY - 2015 JO - Scientific reports DO - 10.1038/srep09384 UR - https://doi.org/10.1038/srep09384 ER -
APA
W, L., Z, J., F, G., X, H., R, H., J, W., S, B., SH, L., H, Z., Y, Y., & YC, C. (2015). PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment.. Scientific reports. https://doi.org/10.1038/srep09384
Source records
- pubmed · retrieved 2026-09-27T09:45:23.318Z